Compartment-Specific Bioluminescence Imaging platform for the high-throughput evaluation of antitumor immune function (Q28383385)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289890%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Compartment-Specific Bioluminescence Imaging platform for the high-throughput evaluation of antitumor immune function (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289890%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

0 references

0 references

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289890%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

11

Kenneth C Anderson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289890%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

9

Paul G Richardson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289890%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

7

Nikhil C Munshi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289890%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

8

Jacob Laubach

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289890%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

2

Jake Delmore

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289890%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Constantine S Mitsiades

12

object named as

Constantine S Mitsiades

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289890%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

6

Robert L Schlossman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289890%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Douglas W McMillin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289890%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Joseph M Negri

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289890%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Matthew Vanneman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289890%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Glenn Dranoff

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289890%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

language of work or name

English

0 references

publication date

30 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289890%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289890%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289890%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289890%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

e131-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289890%20AND%20SRC:MED&resulttype=core&format=json

Lipid accumulation and dendritic cell dysfunction in cancer

21 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325048

Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325048

CD4+ T Cells Contribute to the Remodeling of the Microenvironment Required for Sustained Tumor Regression upon Oncogene Inactivation

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325048

Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325048

Anticancer immunochemotherapy using adjuvants with direct cytotoxic effects

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325048

The anticancer immune response: indispensable for therapeutic success?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325048

Enhancing the clinical activity of granulocyte-macrophage colony-stimulating factor-secreting tumor cell vaccines

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325048

Immunological aspects of cancer chemotherapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325048

Adoptive cell transfer therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325048

Interleukin-21 signaling: functions in cancer and autoimmunity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325048

Immunotherapy of cancer by IL-12-based cytokine combinations

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325048

Immunomodulatory drugs as a therapy for multiple myeloma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325048

Lenalidomide in multiple myeloma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325048

Current therapeutic uses of lenalidomide in multiple myeloma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325048

Myeloma cells are highly sensitive to the granule exocytosis pathway mediated by WT1-specific cytotoxic T lymphocytes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325048

CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325048

The dilemma of anticancer therapy: tumor-specific versus immune effects.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325048

Altered expression of p53 and MDM2 proteins in hematological malignancies.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325048

Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325048

Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3325048

hTERT expression and prognosis in B-chronic lymphocytic leukemia

27 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22289890

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

T lymphocyte engineering ex vivo for cancer and infectious disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22289890

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Standardization of a micro-cytotoxicity assay for human natural killer cell lytic activity

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22289890

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1182/BLOOD-2011-04-348490

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289890%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289890%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

PubMed publication ID

22289890

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289890%20AND%20SRC:MED&resulttype=core&format=json